Home » Newsletters » BioWorld

BioWorld

Feb. 14, 1992

View Archived Issues

INNOVET COMPLETES ACQUISITION

IMMULOGIC FINALIZES AGREEMENT WITH MMD

IAMIN PROMOTES WOUND HEALING IN ULCERS

PATENT FLASH

BLECH TO INVEST IN GYNEX

2-5 YEARS TO SEQUENCE BRAIN GENES

APPLIED IMMUNE RAISES $70 MILLION

NIH TO GO PUBLIC WITH PATENT APPLICATION

GENE THERAPY TRIALS FOR HIV PATIENTS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...